FTC Fights Sage’s Corner In US Apokyn Antitrust Suit

The US Federal Trade Commission has tackled arguments from Supernus Pharmaceuticals, as the firm looks to dismiss an antitrust case alleging that it unlawfully blocked generic competition to its Apokyn (apomorphine) injectable treatment for advanced Parkinson’s Disease.